AVRO
Price:
$1.4
Market Cap:
$5.24M
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter ...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
AVRO
According to AVROBIO, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -85302404.00. This represents a change of -114.65% compared to the average of 582.10M of the last 4 quarters.
The mean historical Enterprise Value of AVROBIO, Inc. over the last ten years is 3.27B. The current -85302404.00 Enterprise Value has changed -360.81% with respect to the historical average. Over the past ten years (40 quarters), AVRO's Enterprise Value was at its highest in in the March 2018 quarter at 8.30B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.
Average
3.27B
Median
2.57B
Minimum
298.87M
Maximum
6.44B
Discovering the peaks and valleys of AVROBIO, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 151.73%
Maximum Annual Enterprise Value = 6.44B
Minimum Annual Increase = -83.44%
Minimum Annual Enterprise Value = 298.87M
Year | Enterprise Value | Change |
---|---|---|
2023 | 625.99M | 109.45% |
2022 | 298.87M | -83.44% |
2021 | 1.81B | -68.86% |
2020 | 5.80B | -9.98% |
2019 | 6.44B | 151.73% |
2018 | 2.56B | -57.75% |
2017 | 6.05B | 134.11% |
The current Enterprise Value of AVROBIO, Inc. (AVRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
910.03M
5-year avg
2.99B
10-year avg
3.27B
AVROBIO, Inc.’s Enterprise Value is less than CohBar, Inc. (-4942363.00), less than Ocean Biomedical, Inc. (44.98M), less than Enveric Biosciences, Inc. (1.02M), less than Elevation Oncology, Inc. (8.41M), less than Zura Bio Limited (42.42M), less than Hepion Pharmaceuticals, Inc. (2.24M), less than eFFECTOR Therapeutics, Inc. (3.83M),
Company | Enterprise Value | Market cap |
---|---|---|
-4942363.00 | $1.25M | |
44.98M | $33.96M | |
1.02M | $4.53M | |
8.41M | $36.94M | |
42.42M | $230.86M | |
2.24M | $4.20M | |
3.83M | $188.18K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AVROBIO, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AVROBIO, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AVROBIO, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AVROBIO, Inc. (AVRO)?
What is the 3-year average Enterprise Value for AVROBIO, Inc. (AVRO)?
What is the 5-year average Enterprise Value for AVROBIO, Inc. (AVRO)?
How does the current Enterprise Value for AVROBIO, Inc. (AVRO) compare to its historical average?